“…Compared with our 6-month course, a 3-month course of PEG-IFN a-2b treatment seems to be less effective. In fact, preliminary data has shown that with the latter approach a sustained virological response was achieved in only 61% of patients, as 33% relapsed after therapy discontinuation [20]. To the contrary, data from a recent Japanese study demonstrated that an even shorter course of daily injections with 6 MU of standard IFN-a for only 4 weeks is effective in 87% of patients [12].…”